The Non-Small Cell Lung Cancer Market covers a global diagnostic and therapeutic space aimed at the most common form of lung cancer, NSCLC. This accounts for around 85% of all cases of lung cancer. The market aims to provide early detection, accurate treatment and long-term treatment decisions for the disease using the outcomes of immunotherapy, targeted therapies and molecular diagno... https://www.metatechinsights.com/industry-insights/non-small-cell-lung-cancer-market-2347